List of companies in Agent Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products. | ||||||
Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases. | ||||||
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics. | ||||||
Orchard Therapeutics is a biotechnology company developing gene therapies for rare diseases. | ||||||
Pliant Therapeutics is a clinical-stage biopharmaceutical company developing treatments for fibrotic diseases with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. | ||||||
Biotechnology software company offering protein modelling and design capabilities. | ||||||
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA). | ||||||
Pyxis Oncology is a company that is developing antibody therapeutics. | ||||||
Entrada Therapeutics is a biologics delivered to cytosol founded in 2016. | ||||||
Immuitas Therapeutics is a company using immunology for complex cancer treatment. | ||||||
Small molecule compounds that act by unlocking protein-protein interfaces | ||||||
Aptinyx Inc. is a company developing treatments in neurology. | ||||||
Immuno-modulatory antibodies | ||||||
Novel methods for in vivo cell-specific gene delivery | ||||||
Glycan engineering platform for the treatment of autoimmune diseases. | ||||||
Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney. | ||||||
Metagenomi Technologies, LLC is a Gene-Edited Microbial Treatments founded in 2018 by Brian C Thomas. | ||||||
biotech company that engages in the novel parvovirus gene therapy | ||||||
Affini-T Therapeutics, Inc is a TCR Cell Therapy. | ||||||
